BARDA's SMART Antiviral Prize is a multi-stage competition to accelerate broad-spectrum small-molecule antivirals targeting the Togaviridae and Flaviviridae families, including chikungunya. The prize pool spans Concept Stage through later development and is open to small-molecule antiviral programs against these viral families.
BARDA announces $100M SMART Antiviral Prize targeting Togaviridae and Flaviviridae
BARDA's SMART Antiviral Prize is a multi-stage competition to accelerate broad-spectrum small-molecule antivirals targeting the Togaviridae and Flaviviridae families, including chikungunya. The prize pool spans Concept Stage through later development and is open to small-molecule antiviral programs against these viral families.